Enanta Pharmaceuticals
ENTA
#8032
Rank
HK$3.01 B
Marketcap
HK$103.68
Share price
-0.75%
Change (1 day)
78.26%
Change (1 year)

Enanta Pharmaceuticals (ENTA) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : HK$1.55 Billion

According to Enanta Pharmaceuticals 's latest financial reports the company's total liabilities are HK$1.55 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Enanta Pharmaceuticals - Total liabilities on balance sheet (from 2011 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-09-30HK$1.68 B-12.75%
2024-09-30HK$1.92 B0.2%
2023-09-30HK$1.92 B352.97%
2022-09-30HK$0.42 B38.51%
2021-09-30HK$0.30 B29.44%
2020-09-30HK$0.23 B10.5%
2019-09-30HK$0.21 B33.21%
2018-09-30HK$0.16 B-17.49%
2017-09-30HK$0.19 B121.62%
2016-09-30HK$87.96 M15.16%
2015-09-30HK$76.37 M45.5%
2014-09-30HK$52.49 M4.05%
2013-09-30HK$50.44 M-20.97%
2012-09-30HK$63.83 M97.81%
2011-09-30HK$32.26 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
HK$938.86 B 60,322.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$624.34 B 40,080.80%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
HK$1.122 T 72,117.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
HK$55.86 B 3,495.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$649.03 B 41,670.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$520.57 B 33,402.43%๐Ÿ‡บ๐Ÿ‡ธ USA